“Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients With Chronic Idiopathic Chronic Spontaneous Urticaria: Results from the X-Act Study”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S53, https://doi.org/10.25251/skin.2.supp.53.